NasdaqGM - Nasdaq Real Time Price • USD
Summit Therapeutics Inc. (SMMT)
As of 12:35 PM EDT. Market Open.
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -0.06 | -0.06 | -0.24 | -0.29 |
| Low Estimate | -0.06 | -0.06 | -0.24 | -0.29 |
| High Estimate | -0.06 | -0.06 | -0.24 | -0.29 |
| Year Ago EPS | -- | -- | -- | -0.24 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| CURRENCY IN USD | ||||
|---|---|---|---|---|
| EPS Est. | -- | -- | -- | -- |
| EPS Actual | -- | -- | -- | -- |
| Difference | -- | -- | -- | -- |
| Surprise % | -- | -- | -- | -- |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.06 | -0.06 | -0.24 | -0.29 |
| 7 Days Ago | -0.06 | -0.06 | -0.24 | -0.29 |
| 30 Days Ago | 0 | 0 | -0.4 | -0.15 |
| 60 Days Ago | 0 | 0 | -0.4 | -0.15 |
| 90 Days Ago | 0 | 0 | -0.4 | -0.15 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | SMMT | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 1.50% |
| Next Qtr. | -- | -- | -- | 11.40% |
| Current Year | -- | -- | -- | 5.20% |
| Next Year | -20.80% | -- | -- | 13.40% |
| Next 5 Years (per annum) | -- | -- | -- | 11.09% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Initiated | Stifel: Buy | 3/26/2024 |
| Downgrade | HC Wainwright & Co.: Buy to Neutral | 11/18/2020 |
| Initiated | HC Wainwright & Co.: Buy | 3/19/2020 |
| Downgrade | Janney Montgomery Scott: Buy to Neutral | 6/28/2018 |
| Downgrade | SunTrust Robinson Humphrey: Buy to Hold | 6/27/2018 |
| Initiated | Janney Montgomery Scott: Buy | 5/2/2018 |
Related Tickers
ALZN Alzamend Neuro, Inc.
0.7001
-1.28%
APGE Apogee Therapeutics, Inc.
45.92
-1.33%
RNAC Cartesian Therapeutics, Inc.
20.89
+0.82%
BCDA BioCardia, Inc.
0.3649
-3.85%
PROK ProKidney Corp.
2.5782
-4.86%
AZTR Azitra, Inc.
0.2150
-4.40%
IGMS IGM Biosciences, Inc.
6.94
-12.88%
VINC Vincerx Pharma, Inc.
0.9025
-2.96%
TCON TRACON Pharmaceuticals, Inc.
1.8500
-2.12%
VRDN Viridian Therapeutics, Inc.
12.60
-3.30%